Cargando…
Neuromuscular junction dysfunctions due to immune checkpoint inhibitors therapy: An analysis of FAERS data in the past 15 years
INTRODUCTION: The adverse effects of neuromuscular junction dysfunctions caused by immune checkpoint inhibitor (ICI) drugs have not been thoroughly assessed in the clinics. OBJECTIVE: To assess the neuromuscular junction dysfunctions in cancer patients with adverse events caused by ICI therapy by se...
Autores principales: | Zhang, Ping, Lao, Donghui, Chen, Haoyan, Zhao, Bin, Du, Qiong, Zhai, Qing, Ye, Xuan, Yu, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9446345/ https://www.ncbi.nlm.nih.gov/pubmed/36081514 http://dx.doi.org/10.3389/fimmu.2022.778635 |
Ejemplares similares
-
Cardiovascular toxicity profiles of immune checkpoint inhibitors with or without angiogenesis inhibitors: a real-world pharmacovigilance analysis based on the FAERS database from 2014 to 2022
por: Wang, Yanfeng, et al.
Publicado: (2023) -
Post-marketing safety surveillance of sacituzumab govitecan: an observational, pharmacovigilance study leveraging FAERS database
por: Liu, Wensheng, et al.
Publicado: (2023) -
NK Cell Dysfunction and Checkpoint Immunotherapy
por: Bi, Jiacheng, et al.
Publicado: (2019) -
Reconstruction of the neuromuscular junction connectome
por: Srinivasan, Ranga, et al.
Publicado: (2010) -
Growth/Differentiation Factor-15 (GDF-15): From Biomarker to Novel Targetable Immune Checkpoint
por: Wischhusen, Jörg, et al.
Publicado: (2020)